Trial
NCT03532425
B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alberta
Collaborators
Gilead Sciences; University of British Columbia
Condition
HIV-1-infection
Intervention
B/F/TAF
Why stopped
Difficulties enrolling participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-14